ANAVEX-7-1037

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameANAVEX-7-1037
Drug Alias Namesigma-ligands (Anavex)sigma receptor modulators (Anavex)ANAVEX 35-3016ANAVEX-27-1041ANAVEX-30-1022 +[9] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated sodium channels blockersMuscarinic acetylcholine receptor M3 antagonistsSigma-2 receptor modulators +[4] 
TargetsSigma-2 receptorMuscarinic acetylcholine receptor M3Voltage-gated sodium channels
Therapy Area/IndicationsProstatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnavex Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnavex Life Sciences Corp
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A